Prellis Biologics aims to eliminate the wait list for human organ transplants and speed up development of vital new drug therapies. Using innovations in 3D printing and stem cell development, Prellis can create tissue and organs with the microvascular systems that are critical for supporting viable human tissue. The company offers a platform that recreates human immunobiology using 3D printed lymph node organoids for antibody discovery and immunogenicity assessment.

Prellis Bio is hiring Immunologists! We are expanding our Externalized Immune System, EXIS™, platform with applications in antibody discovery, immunogenicity, and vaccine screening all in the same platform. Prellis Biologics, Inc. is a privately held company based in the San Francisco Bay Area, CA. Apply at www.prellisbio.com.


SOSV

Cantos

IndieBio

Plug and Play

Civilization Ventures

Khosla Ventures

True Ventures

Celesta Capital

Black Diamond Ventures

Avidity Partners

Lucas Venture Group

Prellis Biologics

COM:PRELLISBIO

Prellis Biologics

Analysis Not Available